Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Adam Koppel files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- BAIN CAPITAL INVESTORS LLC - $134.38M in KLRA purchases and sales in the last 12 months
- Andrew T. Kaplan - $134.38M in KLRA purchases and sales in the last 12 months
- Bain Capital Life Sciences Investors, LLC - $25.00M in KLRA purchases and sales in the last 12 months
- RTW INVESTMENTS, LP - $8.00M in KLRA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Adam Koppel?
Adam Koppel is a corporate insider of Kailera Therapeutics, Inc. (KLRA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Adam Koppel last file a Form 4?
The most recent primary Form 4 on record is dated 20 April 2026, one of 2 filings going back to 2024.
Has Adam Koppel been buying or selling stock?
Recorded transactions: 1 open-market purchase ($25.00M) and 0 open-market sales across all tracked filings.
